Home › Topics › Gluten and Non-Coeliac Sensitivity
Gluten and Non-Coeliac Sensitivity
GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal
SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch
Coeliac disease is a well-defined autoimmune enteropathy affecting around 1% of the population, and wheat allergy is a distinct IgE-mediated condition — both are diagnosable and both require gluten exclusion. Non-coeliac gluten sensitivity is more complicated, and the honest position is that it exists as a symptom experience while its attribution to gluten specifically is not supported in most people who report it: double-blind placebo-controlled rechallenge studies consistently find that only a minority react to gluten itself, while fructans and other FODMAPs in wheat, together with nocebo expectancy, explain a substantial proportion of symptoms (WHO). The clinically important consequence is procedural rather than philosophical: coeliac serology becomes unreliable once gluten has been withdrawn, so the very common pattern of self-diagnosis followed by dietary exclusion forecloses the one diagnosis that genuinely matters, and anyone considering a gluten-free diet should be tested before starting rather than after.
Key messages
THE PROCEDURAL POINT THAT MATTERS MOST: test before excluding gluten, never after
Coeliac serology and duodenal biopsy both become unreliable once gluten has been withdrawn, because the antibodies fall and the villous architecture recovers. The extremely common sequence — symptoms, self-diagnosis, gluten-free diet, later request for testing — forecloses the one diagnosis that genuinely changes management and requires a formal gluten challenge of several weeks to reverse, which many people are unwilling to undertake. Anyone considering a gluten-free diet should be tested first. This single piece of advice is more clinically valuable than any argument about whether non-coeliac gluten sensitivity exists.
SETTLED: coeliac disease and wheat allergy are real, distinct and diagnosable
Coeliac disease is an autoimmune enteropathy affecting around 1% of the population, driven by gluten in genetically susceptible individuals carrying HLA-DQ2 or DQ8, diagnosed by tissue transglutaminase IgA with total IgA, confirmed by duodenal biopsy in most adults, and requiring strict lifelong gluten exclusion to prevent malabsorption, osteoporosis, infertility and a modest increase in small bowel lymphoma risk. Wheat allergy is a separate IgE-mediated condition. Both are objectively testable, and both are under-diagnosed — a substantial majority of coeliac disease remains undetected in most countries.
CONTESTED ATTRIBUTION: symptoms are real; gluten as the cause usually is not
Non-coeliac gluten sensitivity describes people with genuine symptoms — bloating, abdominal pain, altered bowel habit, fatigue, headache, brain fog — that improve on a gluten-free diet in the absence of coeliac disease or wheat allergy. The symptoms are not in doubt. What double-blind placebo-controlled rechallenge studies consistently show is that only a minority reliably react to gluten specifically when they do not know whether they are receiving it, with reported rates typically in the range of 16-30% of those who identify as gluten sensitive. This is a statement about the causal agent, not about the reality of the illness.
THE BETTER EXPLANATION: fructans and other FODMAPs in wheat
Wheat contains fructans, a fermentable oligosaccharide and a major dietary FODMAP source, and a gluten-free diet incidentally removes a large proportion of dietary fructans. Blinded crossover studies, most notably work from Oslo and Monash, have shown that fructan challenge reproduces symptoms in self-reported gluten-sensitive individuals while gluten challenge often does not. This offers a coherent mechanism grounded in osmotic load, colonic fermentation and visceral hypersensitivity, and it explains why a low FODMAP approach frequently succeeds where gluten exclusion has partially helped — and why many such patients are better characterised as having irritable bowel syndrome.
ALSO REAL: nocebo and expectancy effects in an unblinded intervention
Gluten-free eating is an intensely visible, effortful and identity-linked intervention, which maximises expectancy effects in both directions. Rechallenge studies routinely find that a substantial proportion of participants report symptom worsening on placebo, and that symptom scores rise when people believe they have consumed gluten regardless of what they actually consumed. Acknowledging this is not an accusation of imagination — nocebo effects produce measurable physiological changes — but it does mean that unblinded personal experience cannot establish causation, which is precisely why formal rechallenge protocols exist.
THE HARMS OF UNNECESSARY EXCLUSION ARE UNDERSTATED
A gluten-free diet is not nutritionally neutral. Commercial gluten-free replacement products are frequently lower in fibre, iron, folate and B vitamins and higher in fat, sugar and salt than their conventional equivalents, and are substantially more expensive — a genuine equity issue. Reduced whole grain intake has its own cardiovascular implications. There is also the social and psychological cost of restriction, and in a minority the diet becomes a vector for disordered eating. None of this argues against exclusion where it is indicated; it argues for establishing whether it is indicated.
Key statistics
~1%
population prevalence of coeliac disease, with the majority undiagnosed in most countries
BSG/ESsCDTest first
coeliac serology and biopsy become unreliable once gluten is withdrawn — the key practical rule
BSG/NICE16-30%
of self-identified gluten-sensitive people react specifically to gluten on blinded rechallenge
Gastroenterology/GutFructans
reproduce symptoms in blinded challenge where gluten frequently does not
Gastroenterology 2018HLA-DQ2/DQ8
present in almost all coeliac disease — a negative result has high negative predictive value
ESsCDNutritionally poorer
gluten-free replacement products typically lower in fibre and micronutrients and more costly
Nutrients/BDAGluten and wheat sensitivity — where the disagreement actually lies
Glossary of key terms
Latest GMJ coverage

How Diet Shapes Your Gut Microbiome—and Why It Matters for Health
25/07/2026

Coeliac Disease Linked to Increased Death Risk and Cancer in Major US Study
12/06/2026

Vegan, Gluten-Free, Cruelty-Free: What a Manufacturer’s Declaration Is Worth
20/08/2026
Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery
Knowledge hub: guidelines, conventions and reports
Organizations working in migration and health
Related health topics
Coeliac diseaseIBS and the FODMAP approachNutritionWheat allergyRestrictive eating patternsNocebo and expectancy effects
About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team

